Identification of Pattern and Factors Affecting Recurrence in Head and Neck Carcinoma

Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC

NCT02047201 ·Status: COMPLETED ·Phase: PHASE2

The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma

NCT05494190 ·Status: RECRUITING ·Phase: NA

Re-irradiation of Recurrent Head and Neck Cancer

NCT01973179 ·Status: ACTIVE_NOT_RECRUITING

Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT

NCT04996147 ·Status: TERMINATED

A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

NCT03424291 ·Status: UNKNOWN ·Phase: PHASE2

A Study Comparing Hypofractionated Dose Escalated VMAT to Conventional CCRT in Locally Advanced Head and Neck Cancer

NCT03699969 ·Status: UNKNOWN ·Phase: NA

A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

NCT04603248 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Reconstruction of Cervical Lymphatic System During Head and Neck Squamous Cell Carcinoma Surgery

NCT06815705 ·Status: NOT_YET_RECRUITING ·Phase: NA

Nomograms to Precisely Predict Conditional Risk of Recurrence for Patients With Laryngeal Cancer

NCT03595410 ·Status: UNKNOWN

Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck

NCT01527877 ·Status: UNKNOWN ·Phase: PHASE2

Head and Neck Cancer in Children: A Retrospective Study

NCT02557048 ·Status: UNKNOWN

A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer

NCT04405154 ·Status: UNKNOWN ·Phase: PHASE2

Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma

NCT00934518 ·Status: WITHDRAWN ·Phase: PHASE2

Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada

NCT02705833 ·Status: COMPLETED

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

NCT01267240 ·Status: TERMINATED ·Phase: PHASE2

Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection

NCT02918955 ·Status: COMPLETED ·Phase: PHASE3

A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT06668961 ·Status: RECRUITING ·Phase: PHASE2

Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer

NCT00713219 ·Status: COMPLETED ·Phase: PHASE2

Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT01695122 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

NCT06719479 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00096512 ·Status: COMPLETED ·Phase: PHASE2

Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT02277184 ·Status: TERMINATED ·Phase: PHASE1

SHR-1701 in Patients With Recurrent/Metastatic Scchn

NCT04650633 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe

NCT05123950 ·Status: COMPLETED

Effect of Accelerated RTH in Squamous Cell Carcinoma in Head and Neck

NCT05291663 ·Status: UNKNOWN